Overview


According to FutureWise analysis the market for digital pcr (dpcr) and real-time pcr (qpcr) in 2023 is US$ 8.5 billion, and is expected to reach US$ 15.76 billion by 2031 at a CAGR of 8.00%.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Digital PCR (dPCR) and Real-time PCR (qPCR) Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Digital PCR (dPCR) and Real-time PCR (qPCR) Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

  • Abbott Laboratories
  • Agilent Technologies
  • Inc, Analytik Gena AG
  • Becton Dickinson and Company
  • Biomérieux S.A.
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • Hoffman-La Roche Ltd.
  • Fluidigm Corporation
  • Thermo Fisher Scientific, Inc.

(Note: The list of the major players will be updated with the latest market scenario and trends)

By Product and Service

  • qPCR products and services
    • qPCR reagents and consumables
    • qPCR instruments
    • qPCR software and services
  • dPCR products and services
    • dPCR reagents and consumables
    • dPCR instruments
    • qPCR software and services

By Application

  • qPCR applications and dPCR applications
    • Forensic applications
    • Research applications
    • Clinical applications
      • Infectious disease testing
      • Oncology testing
      • Blood screening
      • Transplant diagnostics
      • Other applications

By End User

  • dPCR and qPCR end users
    • Hospitals and diagnostic centres
    • Research Laboratories and Academic Institutes
    • Pharmaceutical and Biotechnology companies
    • Clinical research organizations
    • Forensic laboratories

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa
  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants
  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth
  • To provide with an exhaustive analysis on the Digital PCR (dPCR) and Real-time PCR (qPCR) Market By Product and Service, By Application, By End User and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions
  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Digital PCR (dPCR) and Real-time PCR (qPCR) Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Digital PCR (dPCR) and Real-time PCR (qPCR) Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Digital PCR (dPCR) and Real-time PCR (qPCR) Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Digital PCR (dPCR) and Real-time PCR (qPCR) Market, By Product and Service Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. qPCR products and services
         1.1. qPCR reagents and consumables
         1.2. qPCR instruments
         1.3. qPCR software and services
        2. dPCR products and services
         2.1. dPCR reagents and consumables
         2.2. dPCR instruments
         2.3. dPCR software and services

  • 8.   Digital PCR (dPCR) and Real-time PCR (qPCR) Market, By Application Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. qPCR applications and dPCR applications
         1.1. Forensic applications
         1.2. Research applications
         1.3. Clinical applications
          1.3.1. Infectious disease testing
          1.3.2. Oncology testing
          1.3.3. Blood screening
          1.3.4. Transplant diagnostics
          1.3.5. Other applications

  • 9.   Digital PCR (dPCR) and Real-time PCR (qPCR) Market, By End User Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. dPCR and qPCR end users
         1.1. Hospitals and diagnostic centres
         1.2. Research Laboratories and Academic Institutes
         1.3. Pharmaceutical and Biotechnology companies
         1.4. Clinical research organizations
         1.5. Forensic laboratories

  • 10.   North America Digital PCR (dPCR) and Real-time PCR (qPCR) Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 11.   Latin America Digital PCR (dPCR) and Real-time PCR (qPCR) Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 12.   Europe Digital PCR (dPCR) and Real-time PCR (qPCR) Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 13.   Asia Pacific Digital PCR (dPCR) and Real-time PCR (qPCR) Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 14.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 15.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 16.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Abbott Laboratories
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Agilent Technologies
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Inc, Analytik Gena AG
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Becton Dickinson and Company
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Biomérieux S.A.
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Bio-Rad Laboratories, Inc.
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Danaher Corporation
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Hoffman-La Roche Ltd.
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Fluidigm Corporation
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. Thermo Fisher Scientific, Inc.
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overviews

  • 17.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the regulations initiated by healthcare administrations
        5. The overall economic slowdown of the developing and developed nations
  • 18.   FutureWise SME Key Takeaway Points for Client

FAQ


Digital PCR (dPCR) and real-time PCR (qPCR) are both methods of amplifying DNA, but they differ in detection and quantification. dPCR partitions the sample and performs the amplification in each partition, enabling absolute quantification without the need for standard curves. qPCR monitors the amplification process in real-time with the help of fluorescent markers, providing relative quantification through comparison to standard samples.

The market scope encompasses the development and distribution of dPCR and qPCR technologies and their varied applications across multiple industries. It includes pharmaceutical and biotechnology companies, academic and research institutions, hospitals and diagnostic centers, and others that use dPCR/qPCR for tasks like disease diagnosis, genetic sequencing, and pathogen detection.

The market size for dPCR and qPCR is continually evolving due to advances in technology and increasing application areas. To obtain current market size data, please refer to our recent reports or contact our sales team for up-to-date information.

For both dPCR and qPCR, the quality of the sample DNA/RNA, the efficiency of the PCR amplification, the specificity of the primers and probes, and the precision of the detection system play crucial roles in the accuracy and sensitivity of the assays.

Forecasted trends suggest a growing emphasis on personalized medicine, increased investment in molecular biology research, and the advancement of technology which may reduce costs and improve accessibility and precision. Emerging infectious diseases are also anticipated to drive demand for rapid and accurate quantification methods like dPCR and qPCR.

Partner

Our Clients